Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 2, 2011, Pages 169-180

  Beckman, Lauren M ^a   Beckman, Tiffany R ^b   Sibley, Shalamar D ^b   Thomas, William ^c   Ikramuddin, Sayeed ^b   Kellogg, Todd A ^b   Ghatei, Mohammad A ^d   Bloom, Stephen R ^d   Le Roux, Carel W ^d   Earthman, Carrie P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

gastric bypass; gastrointestinal hormones; ghrelin; glucagon like peptide 1; leptin; obesity; peptide YY

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; PEPTIDE YY;

ADULT; AREA UNDER THE CURVE; ARTICLE; BEVERAGE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET RESTRICTION; FAT INTAKE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN INTAKE; ROUX Y ANASTOMOSIS; STIMULUS RESPONSE;

ADULT; AREA UNDER CURVE; DIETARY FATS; DIETARY PROTEINS; FEMALE; GASTRIC BYPASS; GASTROINTESTINAL HORMONES; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; HUMANS; LEPTIN; MIDDLE AGED; OBESITY, MORBID; PEPTIDE YY; POSTOPERATIVE PERIOD; WEIGHT LOSS;

EID: 79954581831     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607110381403     Document Type: Article

References (107)

1. Brolin RE Bariatric surgery and long-term control of morbid obesity. JAMA. 2002 ; 288: 2793-2796. (Pubitemid 35425059)
2. Smith BR, Schauer P., Nguyen NT Surgical approaches to the treatment of obesity: bariatric surgery. Endocrinol Metab Clin North Am. 2008 ; 37: 943-964.
3. Saliba J., Wattacheril J., Abumrad NN Endocrine and metabolic response to gastric bypass. Curr Opin Clin Nutr Metab Care. 2009 ; 12: 515-521.
4. Buchwald H. ; Consensus Conference Panel. Consensus conference statement bariatric surgery for morbid obesity: health implications for patients, health professionals, and third-party payers. Surg Obes Relat Dis. 2005 ; 1: 371-381.
5. Elder KA, Wolfe BM Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007 ; 132: 2253-2271. (Pubitemid 46693754)
6. Pilkington TR, Gazet JC, Ang L., Kalucy RS, Crisp AH, Day S. Explanations for weight loss after ileojejunal bypass in gross obesity. Br Med J. 1976 ; 1: 1504-1505.
7. Korner J., Inabnet W., Febres G., et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond). 2009 ; 33: 786-795.
8. Toh SY, Zarshenas N., Jorgensen J. Prevalence of nutrient deficiencies in bariatric patients. Nutrition. 2009 ; 25: 1150-1156.
9. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006 ; 93: 210-215. (Pubitemid 43259607)
10. Holdstock C., Zethelius B., Sundbom M., Karlsson FA, Edén Engström B. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond). 2008 ; 32: 1640-1646.
11. le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006 ; 243: 108-114. (Pubitemid 43054062)
12. Baggio LL, Drucker DJ Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007 ; 132: 2131-2157. (Pubitemid 46711096)
13. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007 ; 117: 13-23.
14. Murphy KG, Bloom SR Gut hormones and the regulation of energy homeostasis. Nature. 2006 ; 444: 854-859. (Pubitemid 46024992)
15. Wren AM, Bloom SR Gut hormones and appetite control. Gastroenterology. 2007 ; 132: 2116-2130. (Pubitemid 46693747)
16. Vincent RP, le Roux CW Changes in gut hormones after bariatric surgery. Clin Endocrinol (Oxf). 2008 ; 69: 173-179. (Pubitemid 352009012)
17. Dhillo WS Appetite regulation: an overview. Thyroid. 2007 ; 17: 433-445. (Pubitemid 46878846)
18. Dube PE, Brubaker PL Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm Metab Res. 2004 ; 36: 755-760. (Pubitemid 40115895)
19. Frezza EE, Wachtel MS, Chiriva-Internati M. The multiple faces of glucagon-like peptide-1-obesity, appetite, and stress: what is next? A review. Dig Dis Sci. 2007 ; 52: 643-649.
20. le Roux CW, Bloom SR Peptide YY, appetite and food intake. Proc Nutr Soc. 2005 ; 64: 213-216. (Pubitemid 40813543)
21. Vincent RP, Ashrafian H., le Roux CW Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Nat Clin Pract Gastroenterol Hepatol. 2008 ; 5: 268-277. (Pubitemid 351637912)
22. Jayasena CN, Bloom SR Role of gut hormones in obesity. Endocrinol Metab Clin North Am. 2008 ; 37: 769-787, xi.
23. Van Citters GW, Lin HC The ileal brake: a fifteen-year progress report. Curr Gastroenterol Rep. 1999 ; 1: 404-409.
24. Coppini LZ, Waitzberg DL, Campos AC Limitations and validation of bioelectrical impedance analysis in morbidly obese patients. Curr Opin Clin Nutr Metab Care. 2005 ; 8: 329-332. (Pubitemid 40586193)
25. Deacon CF What do we know about the secretion and degradation of incretin hormones ? Regul Pept. 2005 ; 128: 117-124. (Pubitemid 40380912)
26. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology. 1985 ; 89: 1070-1077. (Pubitemid 16231572)
27. Yoder SM, Yang Q., Kindel TL, Tso P. Stimulation of incretin secretion by dietary lipid: is it dose dependent? Am J Physiol Gastrointest Liver Physiol. 2009 ; 297: G299 - G305.
28. Herrmann C., Goke R., Richter G., Fehmann HC, Arnold R., Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion. 1995 ; 56: 117-126.
29. Maffeis C., Surano MG, Cordioli S., Gasperotti S., Corradi M., Pinelli L. A high-fat vs a moderate-fat meal in obese boys: nutrient balance, appetite, and gastrointestinal hormone changes. Obesity (Silver Spring). 2010 ; 18: 449-455.
30. Bowen J., Noakes M., Clifton PM Appetite regulatory hormone responses to various dietary proteins differ by body mass index status despite similar reductions in ad libitum energy intake. J Clin Endocrinol Metab. 2006 ; 91: 2913-2919. (Pubitemid 44271735)
31. Bowen J., Noakes M., Clifton PM Appetite hormones and energy intake in obese men after consumption of fructose, glucose and whey protein beverages. Int J Obes (Lond). 2007 ; 31: 1696-1703. (Pubitemid 350023160)
32. Essah PA, Levy JR, Sistrun SN, Kelly SM, Nestler JE Effect of macronutrient composition on postprandial peptide YY levels. J Clin Endocrinol Metab. 2007 ; 92: 4052-4055. (Pubitemid 47607660)
33. Maljaars J., Romeyn EA, Haddeman E., Peters HP, Masclee AA Effect of fat saturation on satiety, hormone release, and food intake. Am J Clin Nutr. 2009 ; 89: 1019-1024.
34. Seimon RV, Feltrin KL, Meyer JH, et al. Effects of varying combinations of intraduodenal lipid and carbohydrate on antropyloroduodenal motility, hormone release, and appetite in healthy males. Am J Physiol Regul Integr Comp Physiol. 2009 ; 296: R912 - R920.
35. Helou N., Obeid O., Azar ST, Hwalla N. Variation of postprandial PYY 3-36 response following ingestion of differing macronutrient meals in obese females. Ann Nutr Metab. 2008 ; 52: 188-195. (Pubitemid 351990888)
36. Batterham RL, Heffron H., Kapoor S., et al. Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab. 2006 ; 4: 223-233. (Pubitemid 44307976)
37. Verdich C., Toubro S., Buemann B., Lysgård Madsen J., Juul Holst J., Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord. 2001 ; 25: 1206-1214. (Pubitemid 32721544)
38. Batterham RL, Cohen MA, Ellis SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003 ; 349: 941-948. (Pubitemid 37064767)
39. le Roux CW, Batterham RL, Aylwin SJ, et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology. 2006 ; 147: 3-8. (Pubitemid 43004254)
40. Alvarez Bartolome M., Borque M., Martinez-Sarmiento J., et al. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg. 2002 ; 12: 324-327. (Pubitemid 34621023)
41. le Roux CW, Welbourn R., Werling M., et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007 ; 246: 780-785. (Pubitemid 350035654)
42. Morinigo R., Lacy AM, Casamitjana R., Delgado S., Gomis R., Vidal J. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg. 2006 ; 16: 1594-1601. (Pubitemid 46032812)
43. Whitson BA, Leslie DB, Kellogg TA, et al. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res. 2007 ; 141: 31-39. (Pubitemid 46898439)
44. Korner J., Bessler M., Cirilo LJ, et al. Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin. J Clin Endocrinol Metab. 2005 ; 90: 359-365. (Pubitemid 40116682)
45. Chan JL, Mun EC, Stoyneva V., Mantzoros CS, Goldfine AB Peptide YY levels are elevated after gastric bypass surgery. Obesity (Silver Spring). 2006 ; 14: 194-198. (Pubitemid 46214749)
46. Korner J., Inabnet W., Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels. Obesity (Silver Spring). 2006 ; 14: 1553-1561. (Pubitemid 46214822)
47. Morinigo R., Vidal J., Lacy AM, Delgado S., Casamitjana R., Gomis R. Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg. 2008 ; 247: 270-275. (Pubitemid 351156769)
48. Rodieux F., Giusti V., D'Alessio DA, Suter M., Tappy L. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release. Obesity (Silver Spring). 2008 ; 16: 298-305. (Pubitemid 351271908)
49. Goldfine AB, Mun EC, Devine E., et al. Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007 ; 92: 4678-4685. (Pubitemid 350223444)
50. Korner J., Bessler M., Inabnet W., Taveras C., Holst JJ Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis. 2007 ; 3: 597-601. (Pubitemid 350091417)
51. Morínigo R., Moizé V., Musri M., et al. Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2006 ; 91: 1735-1740.
52. Zwirska-Korczala K., Konturek SJ, Sodowski M., et al. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome. J Physiol Pharmacol. 2007 ; 58 (suppl 1). 13-35. (Pubitemid 350022256)
53. Cummings DE, Purnell JQ, Frayo RS, Schmidova K., Wisse BE, Weigle DS A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001 ; 50: 1714-1719.
54. Erdmann J., Lippl F., Schusdziarra V. Differential effect of protein and fat on plasma ghrelin levels in man. Regul Pept. 2003 ; 116: 101-107. (Pubitemid 37352921)
55. Tannous dit El Khoury D., Obeid O., Azar ST, Hwalla N. Variations in postprandial ghrelin status following ingestion of high-carbohydrate, high-fat, and high-protein meals in males. Ann Nutr Metab. 2006 ; 50: 260-269. (Pubitemid 43829817)
56. Bowen J., Noakes M., Trenerry C., Clifton PM Energy intake, ghrelin, and cholecystokinin after different carbohydrate and protein preloads in overweight men. J Clin Endocrinol Metab. 2006 ; 91: 1477-1483.
57. Foster-Schubert KE, Overduin J., Prudom CE, et al. Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates. J Clin Endocrinol Metab. 2008 ; 93: 1971-1979. (Pubitemid 351656546)
58. Blom WA, Lluch A., Stafleu A., et al. Effect of a high-protein breakfast on the postprandial ghrelin response. Am J Clin Nutr. 2006 ; 83: 211-220. (Pubitemid 44713180)
59. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002 ; 346: 1623-1630.
60. Couce ME, Cottam D., Esplen J., Schauer P., Burguera B. Is ghrelin the culprit for weight loss after gastric bypass surgery? A negative answer. Obes Surg. 2006 ; 16: 870-878. (Pubitemid 44133475)
61. Tritos NA, Mun E., Bertkau A., Grayson R., Maratos-Flier E., Goldfine A. Serum ghrelin levels in response to glucose load in obese subjects post-gastric bypass surgery. Obes Res. 2003 ; 11: 919-924. (Pubitemid 41137501)
62. Lin E., Gletsu N., Fugate K., et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg. 2004 ; 139: 780-784. (Pubitemid 38886515)
63. Morínigo R., Casamitjana R., Moizé V., et al. Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res. 2004 ; 12: 1108-1116. (Pubitemid 41132490)
64. Christou NV, Look D., McLean AP Pre- and post-prandial plasma ghrelin levels do not correlate with satiety or failure to achieve a successful outcome after Roux-en-Y gastric bypass. Obes Surg. 2005 ; 15: 1017-1023. (Pubitemid 41116887)
65. Leonetti F., Silecchia G., Iacobellis G., et al. Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. J Clin Endocrinol Metab. 2003 ; 88: 4227-4231. (Pubitemid 37153724)
66. Engstrom BE, Ohrvall M., Sundbom M., Lind L., Karlsson FA Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery. Int J Obes (Lond). 2007 ; 31: 476-480.
67. Faraj M., Havel PJ, Phelis S., Blank D., Sniderman AD, Cianflone K. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab. 2003 ; 88: 1594-1602. (Pubitemid 36623375)
68. Holdstock C., Engstrom BE, Ohrvall M., Lind L., Sundbom M., Karlsson FA Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. J Clin Endocrinol Metab. 2003 ; 88: 3177-3183. (Pubitemid 36877491)
69. Sundbom M., Holdstock C., Engstrom BE, Karlsson FA Early changes in ghrelin following Roux-en-Y gastric bypass: influence of vagal nerve functionality ? Obes Surg. 2007 ; 17: 304-310. (Pubitemid 46659288)
70. Stoeckli R., Chanda R., Langer I., Keller U. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. Obes Res. 2004 ; 12: 346-350. (Pubitemid 41132559)
71. Karamanakos SN, Vagenas K., Kalfarentzos F., Alexandrides TK Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg. 2008 ; 247: 401-407.
72. Mancini MC, Costa AP, de Melo ME, et al. Effect of gastric bypass on spontaneous growth hormone and ghrelin release profiles. Obesity (Silver Spring). 2006 ; 14: 383-387. (Pubitemid 46219756)
73. Vendrell J., Broch M., Vilarrasa N., et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res. 2004 ; 12: 962-971.
74. Friedman JM Obesity in the new millennium. Nature. 2000 ; 404: 632-634. (Pubitemid 30205067)
75. Schubert ML Gastric secretion. Curr Opin Gastroenterol. 2008 ; 24: 659-664.
76. Bloomgarden ZT Gut and adipocyte peptides. Diabetes Care. 2006 ; 29: 450-456. (Pubitemid 44106537)
77. Konopko-Zubrzycka M., Baniukiewicz A., Wroblewski E., et al. The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J Clin Endocrinol Metab. 2009 ; 94: 1644-1649.
78. Olivan B., Teixeira J., Bose M., et al. Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg. 2009 ; 249: 948-953.
79. Ratliff J., Mutungi G., Puglisi MJ, Volek JS, Fernandez ML Carbohydrate restriction (with or without additional dietary cholesterol provided by eggs) reduces insulin resistance and plasma leptin without modifying appetite hormones in adult men. Nutr Res. 2009 ; 29: 262-268.
80. Weigle DS, Breen PA, Matthys CC, et al. A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations. Am J Clin Nutr. 2005 ; 82: 41-48. (Pubitemid 41716375)
81. Czupryniak L., Pawlowski M., Kumor A., Szymanski D., Loba J., Strzelczyk J. Predicting maximum Roux-en-Y gastric bypass-induced weight reduction-preoperative plasma leptin or body weight ? Obes Surg. 2007 ; 17: 162-167. (Pubitemid 47091576)
82. Fruhbeck G., Diez-Caballero A., Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004 ; 14: 606-612. (Pubitemid 38716579)
83. Molina A., Vendrell J., Gutierrez C., et al. Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. Obes Surg. 2003 ; 13: 615-621. (Pubitemid 36951744)
84. Ramos AP, de Abreu MR, Vendramini RC, Brunetti IL, Pepato MT Decrease in circulating glucose, insulin and leptin levels and improvement in insulin resistance at 1 and 3 months after gastric bypass. Obes Surg. 2006 ; 16: 1359-1364. (Pubitemid 44671810)
85. Rubino F., Gagner M., Gentileschi P., et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004 ; 240: 236-242. (Pubitemid 38963013)
86. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia. 2008 ; 51: 1901-1911.
87. Das SK, Roberts SB, McCrory MA, et al. Long-term changes in energy expenditure and body composition after massive weight loss induced by gastric bypass surgery. Am J Clin Nutr. 2003 ; 78: 22-30. (Pubitemid 39655244)
88. Whitson BA, Leslie DB, Kellogg TA, et al. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. J Surg Res. 2007 ; 142: 295-300. (Pubitemid 47418830)
89. Bobbioni-Harsch E., Morel P., Huber O., et al. Energy economy hampers body weight loss after gastric bypass. J Clin Endocrinol Metab. 2000 ; 85: 4695-4700. (Pubitemid 32157654)
90. Riedl M., Vila G., Maier C., et al. Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab. 2008 ; 93: 2307-2312. (Pubitemid 351831552)
91. Meier CA, Bobbioni E., Gabay C., Assimacopoulos-Jeannet F., Golay A., Dayer JM IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin ? J Clin Endocrinol Metab. 2002 ; 87: 1184-1188. (Pubitemid 36121085)
92. Faraj M., Jones P., Sniderman AD, Cianflone K. Enhanced dietary fat clearance in postobese women. J Lipid Res. 2001 ; 42: 571-580. (Pubitemid 32367000)
93. Hickey MS, Pories WJ, MacDonald KG Jr, et al. A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut ? Ann Surg. 1998 ; 227: 637-644. (Pubitemid 28530913)
94. Savage AP, Adrian TE, Carolan G., Chatterjee VK, Bloom SR Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut. 1987 ; 28: 166-170. (Pubitemid 17027386)
95. Kreymann B., Williams G., Ghatei MA, Bloom SR Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987 ; 2: 1300-1304. (Pubitemid 17156636)
96. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz PH, Barnes AJ Distribution and release of human pancreatic polypeptide. Gut. 1976 ; 17: 940-944. (Pubitemid 8027537)
97. Patterson M., Murphy KG, le Roux CW, Ghatei MA, Bloom SR Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab. 2005 ; 90: 2205-2211. (Pubitemid 40586263)
98. Westerterp-Plantenga MS, Luscombe-Marsh N., Lejeune Mpgm, et al. Dietary protein, metabolism, and body-weight regulation: dose-response effects. Int J Obes. 2006 ; 30: S16 - S23.
99. Soenen S., Westerterp-Plantenga MS Proteins and satiety: implications for weight management. Curr Opin Clin Nutr Metab Care. 2008 ; 11: 747-751.
100. Laferrere B., Teixeira J., McGinty J., et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008 ; 93: 2479-2485. (Pubitemid 352008510)
101. Laferrere B., Heshka S., Wang K., et al. Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes. Diabetes Care. 2007 ; 30: 1709-1716. (Pubitemid 47036341)
102. Clements RH, Gonzalez QH, Long CI, Wittert G., Laws HL Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg. 2004 ; 70: 1-5.
103. Näslund E., Kral J. Impact of gastric bypass surgery on gut hormones and glucose homeostasis in type 2 diabetes. Diabetes. 2006 ; 55 (suppl 2). S92 - S97.
104. Cummings DE, Overduin J., Foster-Schubert KE Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. J Clin Endocrinol Metab. 2004 ; 89: 2608-2615.
105. Vidal J., Nicolau J., Romero F., et al. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab. 2009 ; 94: 884-891.
106. Van Citters GW, Lin HC Ileal brake: neuropeptidergic control of intestinal transit. Curr Gastroenterol Rep. 2006 ; 8: 367-373. (Pubitemid 44515358)
107. Pournaras DJ, Osborne A., Hawkins SC, et al. The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study. Obes Surg. 2009 ; 20: 56-60.